Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

The Effects of Supplementation With ElderCraft® Elderberry Extract: A Randomized, Triple-blind, Placebo Controlled Clinical Trial.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05435144
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:57.401330+00:00
Published At
2022-10-12T00:00:00+00:00
Record Updated At
2022-10-12
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Upper Respiratory Tract Infection", "COVID-19", "Flu", "Flu Like Illness", "Cold"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-10-12"
protocolSection.identificationModule.nctId
"NCT05435144"
protocolSection.identificationModule.officialTitle
"The Effects of Supplementation With ElderCraft\u00ae Elderberry Extract: A Randomized, Triple-blind, Placebo Controlled Clinical Trial."
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Upper Respiratory Tract Infection (protocolSection.conditionsModule.conditions)
  • COVID-19 (protocolSection.conditionsModule.conditions)
  • Flu (protocolSection.conditionsModule.conditions)
  • Flu Like Illness (protocolSection.conditionsModule.conditions)
  • Cold (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.